|
C.D.C. Guidelines for preventing the transmission of
tuberculosis in health care facilities. MMWR 43(RR13):1-132,
1994.
C.D.C. Interim laboratory
biosafety guidance for extensively drug resistant (XDR)
Mycobacterium tuberculosis strains.
CDC/NIH. Biosafety in microbiological and biomedical
laboratories (BMBL), 5th edition. 2007.
Directive 2000/54/EC of the European
Parliament and of the Council of 18 September 2000 on the
protection of workers from risks related to exposure to
biological agents at work. Official Journal of the European
Communities. L262/21.
Herman P, Fauville-Dufaux M, Breyer
D, van Vaerenbergh B, Pauwels K, Dai Do Thi C, Sneyers M, Wanlin
M, Snacken R, Moens W. Biosafety recommendations for the
contained use of Mycobacterium tuberculosis complex
isolated in industrialized countries. Royal Library of Belgium.
2006.
Kim SJ, Lee SH, Kim IS, Kim HJ, Kim SK, Rieder HL. Risk of
occupational tuberculosis in national tuberculosis programme in
Korea. Int. J. Tuberc. Lung Dis. 11:138-142, 2007.
Menzies D, Joshi R, Pai M. Risk of
tuberculosis infection and disease associated with work in
health care settings. Int. J. Tuberc. Lung Dis. 11:593-605,
2007.
Vaquero M, Gomez P, Romero M, Casal M, Spanish Group of
Mycobacteriology. Investigation of biological risk in
mycobacteriology laboratories: a multicentre study Int. J.
Tuberc. Lung Dis. 7:879-885, 2003.
WHO. Laboratory Boisafety Manual.
2004. |
